Literature DB >> 24863693

Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia.

Ryusuke Yamamoto1, Akihiro Yokoyama, Mie Yoneda, Kota Ohashi, Toru Hosoda, Toshiya Kagoo, Saigen Boku, Hironori Ueno, Takahiro Yano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24863693     DOI： 10.1007/s00277-014-2119-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  1 in total

1.  Bridging-to-transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft-versus-host Disease.

Authors:  Koichi Murakami; Hironori Ueno; Takashi Okabe; Toshiya Kagoo; Saigen Boku; Takahiro Yano; Akihiro Yokoyama
Journal:  Hematol Rep       Date:  2017-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.